# Definitive Diagnostics, Inc. — Form D

Definitive Diagnostics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-13. The offering totals $100K, of which $97K was reported sold. Industry: Other Technology.

## Offering

- Filed: 2024-05-13
- Form: D
- Accession: 0002022113-24-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $100K
- Amount sold: $97K
- Remaining: $3K
- Minimum investment: $1
- Investors: 1
- Date of first sale: 2023-08-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-513143

## Issuer

- Name: Definitive Diagnostics, Inc.
- CIK: 0002022113
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 211 EAST 70TH STREET, 3H, NEW YORK, NY, 10021
- Phone: 917-622-1102

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Alan Harris, MD | Executive Officer | New York, NY |
| Ellis Malovany, Ph.D. | Executive Officer | New York, NY |
| Robert Puskas, Ph.D. | Executive Officer | Manchester, MO |

## More

- [CIK 2022113 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2022113&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002022113-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.